Stopped early
Transcutaneous Spinal and Peripheral Stimulation and Wrist Robotic Therapy for Patients With Spastic Stroke
NCT04113525 · Northwell Health · Updated 14 April 2022
- What is being tested
- MyoRegulator™ System
- For
- Spasticity as Sequela of Stroke; Stroke; Stroke Sequelae; Hemiplegia, Spastic; Hemiparesis; Upper Limb Hypertonia; CVA
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 13 people. The full rules are on the registry page.
- Where
- United States
- When
- Starts or started 24 Sept 2019, ends 15 Feb 2022. Registered 2 Oct 2019.
- Results
- None posted yet.
In the researchers' words
The purpose of this study is to investigate if two courses of five consecutive sessions of noninvasive spinal stimulation paired with peripheral nerve stimulation at the forearm provided by an investigational device (Doublestim™/ MyoRegulator™ System - PathMaker Neurosystems Inc.) are able to improve wrist stiffness and motor function, when combined with intensive robotic wrist training program in participants with chronic spastic hemiparesis after stroke.
Sites
- The Feinstein Institutes For Medical Research - Northwell HealthManhasset, New York, United States